Erythropoietin protects against rhabdomyolysis-induced acute kidney injury by modulating macrophage polarization

Erythropoietin (EPO) is a well-known hormone that is clinically used for the treatment of anemia. Very recently, an increasing body of evidence showed that EPO could still regulate bioactivities of macrophages. However, the details about the immunomodulatory effect of EPO on macrophages are not full...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuo, Zhang, Chao, Li, Jiawei, Niyazi, Sidikejiang, Zheng, Long, Xu, Ming, Rong, Ruiming, Yang, Cheng, Zhu, Tongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477572/
https://www.ncbi.nlm.nih.gov/pubmed/28383559
http://dx.doi.org/10.1038/cddis.2017.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477572/
https://www.ncbi.nlm.nih.gov/pubmed/28383559
http://dx.doi.org/10.1038/cddis.2017.104

Ejemplares similares